Cargando…
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease
Chronic liver disease (CLD), including non-alcoholic fatty liver disease (NAFLD) and its advanced form, non-alcoholic steatohepatitis (NASH), affects a significant portion of the population worldwide. NAFLD is characterised by fat accumulation in the liver, while NASH is associated with inflammation...
Autores principales: | Musio, Alessandra, Perazza, Federica, Leoni, Laura, Stefanini, Bernardo, Dajti, Elton, Menozzi, Renata, Petroni, Maria Letizia, Colecchia, Antonio, Ravaioli, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139188/ https://www.ncbi.nlm.nih.gov/pubmed/37108675 http://dx.doi.org/10.3390/ijms24087517 |
Ejemplares similares
-
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
por: Dajti, Elton, et al.
Publicado: (2021) -
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome
por: Dajti, Elton, et al.
Publicado: (2019) -
NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023) -
Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023) -
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives
por: Casciola, Riccardo, et al.
Publicado: (2023)